Stryker (SYK)
(Delayed Data from NYSE)
$335.61 USD
-1.54 (-0.46%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $335.50 -0.11 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Income Statements
Fiscal Year end for Stryker Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 20,498 | 18,449 | 17,108 | 14,351 | 14,884 |
Cost Of Goods | 7,440 | 6,871 | 6,140 | 5,294 | 5,188 |
Gross Profit | 13,058 | 11,578 | 10,968 | 9,057 | 9,696 |
Selling & Adminstrative & Depr. & Amort Expenses | 9,170 | 8,737 | 8,384 | 6,834 | 6,983 |
Income After Depreciation & Amortization | 3,888 | 2,841 | 2,584 | 2,223 | 2,713 |
Non-Operating Income | -215 | -158 | -303 | -269 | -151 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 3,673 | 2,683 | 2,281 | 1,954 | 2,562 |
Income Taxes | 508 | 325 | 287 | 355 | 479 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 3,165 | 2,358 | 1,994 | 1,599 | 2,083 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 3,165 | 2,358 | 1,994 | 1,599 | 2,083 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 4,916 | 3,839 | 3,574 | 3,035 | 3,491 |
Depreciation & Amortization (Cash Flow) | 1,028 | 998 | 990 | 812 | 778 |
Income After Depreciation & Amortization | 3,888 | 2,841 | 2,584 | 2,223 | 2,713 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 383.70 | 382.20 | 382.30 | 380.30 | 379.90 |
Diluted EPS Before Non-Recurring Items | 10.60 | 9.34 | 9.09 | 7.43 | 8.26 |
Diluted Net EPS (GAAP) | 8.25 | 6.17 | 5.21 | 4.20 | 5.48 |
Fiscal Year end for Stryker Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 5,815.00 | 4,909.00 | 4,996.00 | 4,778.00 |
Cost Of Goods | NA | 2,112.00 | 1,751.00 | 1,815.00 | 1,762.00 |
Gross Profit | NA | 3,703.00 | 3,158.00 | 3,181.00 | 3,016.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2,446.00 | 2,227.00 | 2,216.00 | 2,281.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,257.00 | 931.00 | 965.00 | 735.00 |
Non-Operating Income | NA | -31.00 | -62.00 | -66.00 | -56.00 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 1,226.00 | 869.00 | 899.00 | 679.00 |
Income Taxes | NA | 83.00 | 177.00 | 161.00 | 87.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1,143.00 | 692.00 | 738.00 | 592.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 1,143.00 | 692.00 | 738.00 | 592.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 383.90 | 384.00 | 383.90 | 383.20 |
Diluted EPS Before Non-Recurring Items | NA | 3.46 | 2.46 | 2.54 | 2.14 |
Diluted Net EPS (GAAP) | NA | 2.98 | 1.80 | 1.93 | 1.54 |